These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35589252)

  • 1. Long-term albumin treatment in patients with cirrhosis and ascites.
    Caraceni P; O'Brien A; Gines P
    J Hepatol; 2022 Jun; 76(6):1306-1317. PubMed ID: 35589252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALBUMIN VERSUS STANDARD MEDICAL TREATMENT IN BRAZILIAN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS.
    Terra C; Viayna E; Ayzin L; Fuster C; Aceituno S; Tafla C
    Arq Gastroenterol; 2023; 60(3):356-363. PubMed ID: 37792766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we incorporate long-term use of albumin for patients with decompensated cirrhosis into our daily clinical practice?
    Uriz Otano J; López López S; Fernández Rodríguez C
    Rev Esp Enferm Dig; 2023 Aug; 115(8):414-417. PubMed ID: 36454075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of albumin infusion in cirrhosis-associated complications.
    Heybe MA; Mehta KJ
    Clin Exp Med; 2024 Mar; 24(1):58. PubMed ID: 38551716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective.
    Moctezuma-Velazquez C; Castro-Narro G; Simó P; Viayna E; Aceituno S; Soler M; Torre A
    Ann Hepatol; 2022; 27(2):100673. PubMed ID: 35074476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
    Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
    J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
    Caraceni P; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Boccia S; Svegliati-Baroni G; Fagiuoli S; Romanelli RG; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Tortora A; De Marco R; Angelico M; Cacciola I; Elia G; Federico A; Massironi S; Guarisco R; Galioto A; Ballardini G; Rendina M; Nardelli S; Piano S; Elia C; Prestianni L; Cappa FM; Cesarini L; Simone L; Pasquale C; Cavallin M; Andrealli A; Fidone F; Ruggeri M; Roncadori A; Baldassarre M; Tufoni M; Zaccherini G; Bernardi M;
    Lancet; 2018 Jun; 391(10138):2417-2429. PubMed ID: 29861076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of albumin in the treatment of decompensated liver cirrhosis.
    Trebicka J
    Curr Opin Gastroenterol; 2022 May; 38(3):200-205. PubMed ID: 35275900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc.
    Grüngreiff K; Gottstein T; Reinhold D; Blindauer CA
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [News for usage of albumin in patients with liver disease].
    Cremonese C; Uschner FE; Trebicka J
    Dtsch Med Wochenschr; 2020 Jun; 145(11):722-726. PubMed ID: 32492740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can albumin reduce the mortality of patients with cirrhosis and ascites? A meta-analysis of randomized controlled trials.
    Xu T; Liu W; Huang R
    Eur J Gastroenterol Hepatol; 2023 Jan; 35(1):80-88. PubMed ID: 36165067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour.
    Laffi G; Gentilini P; Romanelli RG; La Villa G
    Dig Liver Dis; 2003 Sep; 35(9):660-3. PubMed ID: 14563190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin administration in internal medicine: A journey between effectiveness and futility.
    Pompili E; Zaccherini G; Baldassarre M; Iannone G; Caraceni P
    Eur J Intern Med; 2023 Nov; 117():28-37. PubMed ID: 37423819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
    Di Pascoli M; Fasolato S; Piano S; Bolognesi M; Angeli P
    Liver Int; 2019 Jan; 39(1):98-105. PubMed ID: 30230204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.
    Caraceni P; Tufoni M; Zaccherini G; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Simone L; Svegliati-Baroni G; Fagiuoli S; Laffi G; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Gasbarrini A; De Marco R; Piano S; Nardelli S; Elia C; Roncadori A; Baldassarre M; Bernardi M;
    J Hepatol; 2021 Feb; 74(2):340-349. PubMed ID: 32853747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.
    Ashour AA; Atta MA; Sadek KW; Obaid KR; Ashour MA; Ashour A; Danjuma MI; Doi SA; ElZouki AN
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):479-486. PubMed ID: 32976190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards.
    Gentilini P; Bernardi M; Bolondi L; Craxi A; Gasbarrinie G; Ideo G; Laffi G; La Villa G; Salerno F; Ventura E; Pulazzini A; Segantini L; Romanelli RG
    Dig Liver Dis; 2004 Aug; 36(8):539-46. PubMed ID: 15334775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.
    Torp N; Israelsen M; Coenraad M; Papp M; Shawcross D; Korenjak M; Angeli P; Laleman W; Juanola A; Gines P; Trebicka J; Krag A;
    BMJ Open; 2024 Feb; 14(2):e079309. PubMed ID: 38355195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
    Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
    Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.